Supplement RAND Appropriateness Panel to Determine The
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Thorax Supplement RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic ǂ*Mark JD Griffiths FRCP1,2,3, *Susanna Meade MB ChB 4, *Charlotte Summers PhD5, *Danny F McAuley MD6, *Alastair G Proudfoot FRCP1,3,8, Marta Montero Baladia9, Paul Dark PhD10, Kate Diomede MB ChB11 Simon J. Finney FRCA1,3, Lui G Forni PhD12, Christopher Meadows FRCP 4, Ian A Naldrett MSc13,14, Brijesh V. Patel FFICM14,15 Gavin D. Perkins MD16, Mark A Samaan MB BS4, Laurence Sharifi FRCA9, Ganesh Suntharalingam FRCA17,18, Nicholas T Tarmey FFICM19, Matt P Wise DPhil20, Harriet F Young MRCP1, Peter M Irving MD4,7 1 Barts Heart Centre, St Bartholomew’s Hospital, London, UK. 2 National Heart & Lung Institute, Imperial College London, London, UK. 3 William Harvey Research Institute, Queen Mary University of London, London, UK. 4 Guy’s and St Thomas’ NHS Foundation Trust, London, UK. 5 Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 6 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast and Regional Intensive Care Unit, Royal Victoria Hospital, Belfast UK. 7 School of Immunology and Microbial Sciences, King's College London, UK. 8 Nightingale Hospital, London, UK. 9 Barts & The London School of Anaesthesia, The Royal London Hospital, Whitechapel, London, E1 1BB, UK.
[Show full text]